当前位置: X-MOL 学术J. Hepato Biliary Pancreat. Sci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Clinical impact of recombinant thrombomodulin administration on disseminated intravascular coagulation due to severe acute cholangitis (Recover-AC study)
Journal of Hepato-Biliary-Pancreatic Sciences ( IF 3.2 ) Pub Date : 2021-05-22 , DOI: 10.1002/jhbp.998
Takeshi Ogura 1 , Takaaki Eguchi 2 , Kazunari Nakahara 3 , Yoshihide Kanno 4 , Shunsuke Omoto 5 , Masahiro Itonaga 6 , Taira Kuroda 7 , Akitoshi Hakoda 1 , Seitaro Ikeoka 2 , Megumi Takagi 2 , Akihiko Okada 2 , Junya Sato 3 , Ryo Morita 3 , Yousuke Michikawa 3 , Kei Ito 4 , Shinsuke Koshita 4 , Mamoru Takenaka 5 , Masayuki Kitano 6 , Mitsuhito Koizumi 7 , Kazuhide Higuchi 1
Affiliation  

Recombinant thrombomodulin (rhTM) is potentially effective in the treatment of disseminated intravascular coagulation (DIC). Several studies related to drugs for the treatment of acute cholangitis have shown negative results in improvement of overall survival (OS) with rhTM. The aim of this multicenter study was to evaluate the clinical effectiveness of rhTM in patients with acute cholangitis and sepsis-induced DIC who underwent biliary drainage.

中文翻译:

重组凝血调节蛋白给药对严重急性胆管炎引起的弥散性血管内凝血的临床影响(Recover-AC 研究)

重组血栓调节蛋白 (rhTM) 可有效治疗弥散性血管内凝血 (DIC)。几项与治疗急性胆管炎药物相关的研究表明,rhTM 在改善总生存期 (OS) 方面取得了负面结果。这项多中心研究的目的是评估 rhTM 在接受胆道引流的急性胆管炎和脓毒症诱发的 DIC 患者中的临床疗效。
更新日期:2021-05-22
down
wechat
bug